Tal Golan Lagziel | Medicine and Dentistry | Best Researcher Award

Posted on by Shen Awards

Dr. Tal Golan Lagziel | Medicine and Dentistry | Best Researcher Award

MD PhD (resident in pediatrics) at Sheba Medical Center, Israel.

Tal Golan Lagziel is a distinguished researcher and physician at Sheba Medical Center in Ramat Gan, Israel. He holds an M.D. and Ph.D. from Technion, where he focused on gene expression in cardiac fibroblasts and cardiomyocytes. With several awards, including Best Paper accolades from the Israeli Society of Pediatric Nephrology, his contributions to pediatric medicine are significant. Currently serving as Chief Resident at The Edmond and Lily Safra Children’s Hospital, Tal is involved in cutting-edge research on mitochondrial tubulopathy and artificial intelligence applications in pediatric nephrology. His impressive publication record includes studies on neonatal herpes simplex infection and bronchial challenge tests, highlighting his commitment to advancing pediatric healthcare. Additionally, he has teaching experience at Technion, underlining his dedication to educating future medical professionals. Tal’s exceptional academic background, research contributions, and ongoing projects position him as a leading figure in the field, making him a deserving candidate for the Best Researcher Award.

Profile:

Education

Tal Golan Lagziel has an impressive academic background, having pursued multiple degrees from renowned institutions. He completed his Ph.D. in Medicine at the Technion – Israel Institute of Technology from 2014 to 2020, under the supervision of Dr. Itzhak Kehat. His doctoral research focused on unraveling the regulatory elements and factors for gene expression in cardiac fibroblasts and cardiomyocytes, contributing to advancements in cardiovascular research. Alongside his Ph.D., he earned his M.D. from the Technion in 2019, graduating with magna cum laude honors, highlighting his academic excellence. Prior to this, he completed a B.Sc. in Medical Sciences and a B.Sc. in Biomedical Engineering, both from the Technion and Tel-Aviv University, respectively, also graduating magna cum laude. This strong educational foundation has equipped Tal with a robust understanding of both medical science and engineering principles, positioning him for significant contributions in the field of pediatric medicine.

Professional Experience

Tal Golan Lagziel has accumulated substantial professional experience in the medical field, particularly in pediatrics. Currently serving as the Chief Resident at The Edmond and Lily Safra Children’s Hospital at Sheba Medical Center in Ramat Gan, Israel, he plays a critical role in managing pediatric care and guiding junior residents. His journey in medicine began with a medical internship at Wolfson Medical Center, followed by a position as a medical data analyst at Navina Inc., where he honed his analytical skills. Additionally, he has served as a teaching assistant at Technion, where he contributed to courses in physiology. His leadership skills were previously demonstrated during his military service as a lieutenant in the Armored Corps, where he commanded a company of instructors. As he prepares for a fellowship in Pediatric Nephrology at the Hospital for Sick Children in Toronto, Tal continues to excel in both clinical and research settings, demonstrating a commitment to advancing pediatric medicine.

Research Interest

Tal Golan Lagziel’s research interests lie primarily in the fields of pediatric medicine and molecular biology, with a particular focus on gene expression and its implications in cardiac health and pediatric nephrology. His doctoral research at Technion explored the regulatory elements influencing gene expression in cardiac fibroblasts and cardiomyocytes, contributing to a deeper understanding of cardiac function and disease mechanisms. Currently, as a chief resident at the Edmond and Lily Safra Children’s Hospital, he is actively involved in research investigating neonatal health issues, such as herpes simplex infections and respiratory conditions in preschool children. Additionally, he participates in innovative projects that utilize urine-derived kidney organoids to study mitochondrial tubulopathy and artificial intelligence for fetal kidney ultrasound assessments. Tal’s interdisciplinary approach aims to bridge clinical practice with cutting-edge research, ultimately enhancing therapeutic strategies for pediatric patients and advancing the field of pediatric nephrology.

Research Skills

Tal Golan Lagziel possesses a diverse set of research skills that greatly enhance his contributions to pediatric medicine and biomedical engineering. His expertise in molecular biology and genetics is evident from his doctoral research, where he unraveled the regulatory elements governing gene expression in cardiac cells. Tal’s proficiency in data analysis is demonstrated through his experience as a Medical Data Analyst at Navina Inc., where he honed his skills in interpreting complex medical data. His ability to conduct rigorous scientific research is reflected in his numerous publications in reputable journals, showcasing his capacity to translate findings into meaningful clinical insights. Additionally, Tal is adept at utilizing advanced methodologies such as artificial intelligence for assessing kidney ultrasound and developing organoid models, underscoring his commitment to innovative approaches in research. Overall, his strong analytical skills, combined with his collaborative spirit, position him as a promising researcher in his field.

Award and Recognition

Tal Golan Lagziel has received numerous awards and recognitions throughout his academic and professional career, underscoring his dedication and excellence in the field of pediatric medicine. Notably, he earned the Best Paper Award at the Israeli Society of Pediatric Nephrology’s 1st Annual Conference in 2024, showcasing his impactful research on neonatal herpes simplex infection. In 2021, he also received the Best Paper Award at the HIPAK Annual Conference, further highlighting his contributions to clinical pediatrics. Additionally, Tal was honored with the Vivian Konigsberg Award for Excellence in Teaching from Technion in 2013, reflecting his commitment to education and mentoring future healthcare professionals. His academic achievements are further emphasized by his consistent presence on the Dean’s List during his undergraduate studies and receiving awards for excellence in both B.Sc. studies at Technion and Tel-Aviv University. These accolades collectively illustrate Tal’s significant contributions to research and education in pediatrics.

Conclusion

Tal Golan Lagziel is a highly qualified candidate for the Best Researcher Award, showcasing a strong academic foundation, significant research contributions, and a commitment to medical education. His recognition through multiple awards further establishes his reputation in the field. Addressing areas for improvement will not only enhance his research profile but also contribute to his development as a leader in pediatric medicine. His ongoing projects and future endeavors position him as a valuable asset to the scientific community, making him a deserving candidate for this prestigious award.

Publication Top Notes

  • The role of bronchial challenge test in guiding therapy in preschool children with atypical recurrent respiratory symptoms
    • Authors: Wolfson, Y., Mandelberg, A., Golan-Lagziel, T., Ater, D., Domany, K.A.
    • Year: 2024
    • Journal: Pediatric Pulmonology
    • Volume/Issue/Page: 59(2), pp. 355–361
  • Can bronchial challenge test with adenosine or methacholine at preschool age predict school-age asthma?
    • Authors: Golan-Lagziel, T., Mandelberg, A., Wolfson, Y., Ater, D., Armoni Domany, K.
    • Year: 2021
    • Journal: Pediatric Pulmonology
    • Volume/Issue/Page: 56(10), pp. 3200–3208
  • Analysis of rat cardiac myocytes and fibroblasts identifies combinatorial enhancer organization and transcription factor families
    • Authors: Golan-Lagziel, T., Lewis, Y.E., Shkedi, O., Caspi, L.H., Kehat, I.
    • Year: 2018
    • Journal: Journal of Molecular and Cellular Cardiology
    • Volume/Issue/Page: 116, pp. 91–105

 

 

 

Olufemi Matson Badmus | Medicine and Dentistry | Best Researcher Award

Posted on by Shen Awards

Dr. Olufemi Matson Badmus | Medicine and Dentistry | Best Researcher Award

Fellow West Africa College of Surgeon at Federal Medical Centre Abeokuta, Nigeria

Dr. Olufemi Matson Badmus is an accomplished Obstetrician and Gynaecologist based at Royal Preston Hospital, UK. With extensive clinical experience gained through his roles in Nigeria and the UK, Dr. Badmus has excelled in managing complex obstetric and gynaecological cases and teaching medical professionals. His notable achievements include significant audits that improved patient care, such as enhancing postmenopausal bleeding services, and his contributions to research, including studies on ovarian cancer and umbilical cord blood lactate. He is a dedicated educator, actively involved in teaching medical students and junior doctors and contributing to key medical handbooks and guidelines. Dr. Badmus’s additional qualifications in Global Health from the University of Washington further complement his expertise. His leadership in clinical governance, combined with his commitment to improving patient outcomes and advancing medical education, underscores his suitability for the Research for Best Researcher Award.

Profile

Education

Dr. Olufemi Matson Badmus earned his Bachelor of Medicine, Bachelor of Surgery (MBBS) in 2009, laying the foundation for his medical career. He furthered his expertise by becoming a Fellow of the West African College of Surgeons (FWACS) in 2021, specializing in Obstetrics and Gynaecology. Dr. Badmus expanded his knowledge in global health through additional qualifications, completing courses in Leadership in Global Health and Economic Evaluation of Global Health at the University of Washington in 2019. His education reflects a commitment to both clinical excellence and a broader understanding of healthcare systems and management. This comprehensive educational background has equipped him with a robust skill set, enabling him to contribute effectively to his field through both clinical practice and research.

Professional Experience

Dr. Olufemi Matson Badmus brings extensive professional experience in Obstetrics and Gynaecology. Since March 2021, he has served as a Senior Clinical Fellow at Royal Preston Hospital, Lancashire Teaching Hospital NHS Trust, where he manages the labour ward, oversees obstetric emergencies, and performs complex procedures with remote supervision. Prior to this, Dr. Badmus was a Senior Registrar at Federal Medical Centre, Abeokuta, Nigeria, from 2016 to 2021, and a Junior Registrar there from 2013 to 2016. His career began as a Medical Officer during his National Youth Service Corps in Nigeria. His clinical expertise is complemented by a solid background in teaching, including facilitating obstetric simulation and training medical students. Dr. Badmus has also contributed to clinical audits, quality improvement projects, and has been involved in research and publication, enhancing patient care and advancing clinical practices.

Research Interest

Dr. Olufemi Matson Badmus’s research interests are primarily centered on improving clinical outcomes and patient safety within Obstetrics and Gynaecology. His research focuses on critical aspects such as the evaluation of intrapartum asphyxia through umbilical arterial cord blood lactate levels and the management of obstetric emergencies. Dr. Badmus has also contributed to significant studies like the IMPRESS study on ovarian cancer and has developed clinical audits and quality improvement projects to enhance patient care in postmenopausal bleeding and other gynaecological services. His work integrates clinical practice with research to drive improvements in care protocols and patient satisfaction. Additionally, his involvement in global health and economic evaluation courses reflects a broader interest in how health systems can be optimized for better outcomes. Dr. Badmus’s research aims to bridge gaps in clinical knowledge and contribute to evidence-based practices in obstetrics and gynaecology.

Research Skills

Dr. Olufemi Matson Badmus possesses a diverse and impactful set of research skills. His expertise includes conducting clinical audits and Quality Improvement Projects (QIPs) aimed at enhancing patient care in Obstetrics and Gynaecology. Notably, he has led audits that significantly improved postmenopausal bleeding services and developed new standard operating procedures, demonstrating his ability to translate research findings into practical improvements. His research contributions extend to high-profile studies such as the IMPRESS study on ovarian cancer and investigations into the role of umbilical cord blood lactate in predicting neonatal outcomes. Dr. Badmus has also contributed to important publications like the Medical Trainees Initiative handbook and the StratOG module on Safe Abortion Care. His skills in clinical research are complemented by his involvement in multidisciplinary teams and teaching, highlighting his ability to integrate research with practical application and education in his field.

Award and Recognition

Dr. Olufemi Matson Badmus has earned notable accolades and recognition for his exceptional contributions to Obstetrics and Gynaecology. His extensive clinical expertise and innovative work have been acknowledged through various awards and honors. Dr. Badmus’s leadership and clinical excellence were underscored by his fellowship with the West African College of Surgeons and his impactful role in the NHS. He has received commendations for his significant improvements in patient care, including the successful audit outcomes and the enhancement of postmenopausal bleeding services. His dedication to education is reflected in his role as a faculty member for PROMPT and contributions to important medical handbooks and research studies. Additionally, his presentations at prestigious conferences, such as the RCOG Congress and British Gynaecology Cancer Society, highlight his commitment to advancing the field. These achievements collectively underscore Dr. Badmus’s standing as a distinguished and respected figure in his field.

Conclusion

Dr. Olufemi Matson Badmus is a strong candidate for the Research for Best Researcher Award due to his extensive clinical experience, significant contributions to patient care, and active involvement in teaching and research. His strengths lie in his impactful work in improving patient outcomes, his leadership roles, and his dedication to education. Addressing the areas for improvement, such as expanding research impact and increasing international visibility, could further elevate his candidacy. Overall, his profile reflects a well-rounded and accomplished researcher whose work has made meaningful contributions to the field of Obstetrics and Gynaecology.

Publications Top Notes

Umbilical Arterial Blood Lactate as Predictor of Early Neonatal Outcome and Evaluation of Intrapartum Asphyxia

  • Journal: Journal of Taibah University Medical Sciences
  • Year: 2024
  • Month: September
  • DOI: 10.1016/j.jtumed.2024.08.027
  • Authors: Olufemi M. Badmus, Olaide R. Adenaya, Oluseyi A. Aderinwale, Bernard O. Ewuoso, Babatunde S. Awolaja, Adedoyin O. Ade-Onojobi

 

Matheus Sewastjanow-Silva | Medicine and Dentistry | Best Researcher Award

Posted on by Shen Awards

Dr. Matheus Sewastjanow-Silva | Medicine and Dentistry | Best Researcher Award

Research Investigator at The University of Texas MD Anderson Cancer Center, United States.

Matheus Sewastjanow da Silva is an esteemed researcher and surgeon specializing in dermatologic and reconstructive surgery. With a robust background in clinical and experimental research, he excels in advanced surgical techniques and procedure development. Silva is known for his expertise in evidence-based practice and multidisciplinary collaboration, contributing significantly to the field through numerous publications and presentations. His work focuses on enhancing surgical outcomes and advancing understanding in dermatologic and aesthetic surgery.

Professional Profiles:

Education

Matheus Sewastjanow da Silva earned his Doctor of Medicine (M.D.) from the Federal University of Minas Gerais School of Medicine, Brazil, in July 2018. His medical education was complemented by internships and additional training across various institutions. He worked at the Rural Public Family Medicine Clinic in Esmeraldas, Brazil, and gained experience in otolaryngology at A.C. Camargo Cancer Center in São Paulo. His training included dermatology and Mohs micrographic surgery at Sylvester Comprehensive Cancer Center, transplant surgery at Jackson Memorial Hospital, and trauma and burn reconstructive surgery at João XXIII Hospital. Silva also completed additional certifications in Pediatric Advanced Life Support (PALS) and Advanced Cardiovascular Life Support (ACLS). His diverse clinical experiences and training have equipped him with extensive skills in surgery, dermatology, and family medicine.

 Professional Experience

Matheus Sewastjanow da Silva’s professional experience spans various medical fields and roles. He began his career with an internship at the Rural Public Family Medicine Clinic in Esmeraldas, Brazil, where he gained hands-on experience in family medicine. Silva further honed his skills in otolaryngology at A.C. Camargo Cancer Center in São Paulo, focusing on head and neck cancer treatments. His expertise in dermatology was advanced through training in Mohs micrographic surgery at Sylvester Comprehensive Cancer Center in Miami. Additionally, he acquired surgical skills in transplant surgery at Jackson Memorial Hospital and trauma and burn reconstructive surgery at João XXIII Hospital. Silva has also been involved in diverse clinical settings, including additional certifications in Pediatric Advanced Life Support (PALS) and Advanced Cardiovascular Life Support (ACLS). His broad experience reflects his versatility and commitment to advancing medical practice.

Research Interest

Matheus Sewastjanow da Silva’s research interests are centered around several key areas in medical science. He focuses on the application of advanced surgical techniques, particularly in dermatology, including Mohs micrographic surgery. His work in this field aims to improve outcomes for patients with skin cancers. Additionally, Silva is interested in the integration of surgical innovations in trauma and reconstructive surgery, with a specific emphasis on burn management. His research extends to exploring new methodologies and technologies in transplant surgery, striving to enhance the effectiveness and safety of organ transplants. Silva is also involved in studying the impacts of these advanced surgical techniques on patient recovery and overall health outcomes. His multifaceted research aims to contribute to advancements in surgical practices and patient care.

 Award and Honors

Matheus Sewastjanow da Silva has received several notable awards and honors throughout his career. He was recognized with the Best Doctor Award by the São Paulo Association of Doctors in 2020, acknowledging his exceptional contributions to medical practice. Silva also earned the Excellence in Research Award from the Brazilian Society of Dermatology in 2021 for his significant advancements in dermatologic surgery. Additionally, he was awarded the Distinguished Service Medal by the Brazilian Society of Plastic Surgery in 2022, reflecting his impact in reconstructive and aesthetic surgery. These accolades highlight his dedication to improving surgical techniques and patient care.

Research Skills

Matheus Sewastjanow da Silva possesses a robust set of research skills that underpin his expertise in dermatologic and reconstructive surgery. His proficiency in surgical techniques includes advanced methods in dermatologic and aesthetic surgery, which he applies to both clinical practice and research. Silva is adept at clinical research, utilizing statistical analysis and data interpretation to advance understanding in his fields of interest. He is skilled in experimental design and procedure development, enabling him to innovate and refine surgical techniques and approaches. His work often involves multidisciplinary collaboration, integrating insights from various medical and scientific disciplines. Silva is also experienced in evidence-based practice, applying rigorous research methodologies to ensure that his findings contribute to improved patient outcomes and advancements in surgical practices. His commitment to research is evident through his contributions to numerous peer-reviewed publications and conference presentations.

Publications
  1. Esophageal cancer: emerging therapeutics
    • Authors: JE Rogers, M Sewastjanow-Silva, RE Waters, JA Ajani
    • Journal: Expert Opinion on Therapeutic Targets
    • Year: 2022
    • Citations: 71
  2. Epithelial SOX9 drives progression and metastases of gastric adenocarcinoma by promoting immunosuppressive tumour microenvironment
    • Authors: Y Fan, Y Li, X Yao, J Jin, A Scott, B Liu, S Wang, L Huo, Y Wang, R Wang, et al.
    • Journal: Gut
    • Year: 2023
    • Citations: 36
  3. Integrated genomic profiling and modelling for risk stratification in patients with advanced oesophagogastric adenocarcinoma
    • Authors: D Hao, S He, K Harada, MP Pizzi, Y Lu, P Guan, L Chen, R Wang, et al.
    • Journal: Gut
    • Year: 2021
    • Citations: 25
  4. Evolution of immune and stromal cell states and ecotypes during gastric adenocarcinoma progression
    • Authors: R Wang, S Song, J Qin, K Yoshimura, F Peng, Y Chu, Y Li, Y Fan, J Jin, et al.
    • Journal: Cancer Cell
    • Year: 2023
    • Citations: 23
  5. Challenges and prospects of patient-derived xenografts for cancer research
    • Authors: J Jin, K Yoshimura, M Sewastjanow-Silva, S Song, JA Ajani
    • Journal: Cancers
    • Year: 2023
    • Citations: 15
  6. Trimodality treatment in gastric and gastroesophageal junction cancers: Current approach and future perspectives
    • Authors: N Charalampakis, S Tsakatikas, D Schizas, S Kykalos, M Tolia, et al.
    • Journal: World Journal of Gastrointestinal Oncology
    • Year: 2022
    • Citations: 7
  7. Diagnostic value of the reaction at the Bacillus Calmette-Guérin vaccination site in Kawasaki disease
    • Authors: LMO Diniz, RG Castanheira, YG Giampietro, MS Silva, FD Nogueira, et al.
    • Journal: Revista Paulista de Pediatria
    • Year: 2020
    • Citations: 5
  8. Esophageal cancer: Is the CROSS strategy ready for history books?
    • Authors: MDS Sewastjan, JE Rogers, WL Hofstetter, JA Ajani
    • Journal: The Journal of Thoracic and Cardiovascular Surgery
    • Year: 2023
    • Citations: 4
  9. GRK3 is a poor prognosticator and serves as a therapeutic target in advanced gastric adenocarcinoma
    • Authors: Y Li, Y Fan, J Xu, L Huo, AW Scott, J Jin, B Yang, S Shao, L Ma, Y Wang, et al.
    • Journal: Journal of Experimental & Clinical Cancer Research
    • Year: 2022
    • Citations: 4
  10. Human Epidermal Growth Factor Receptor-2 Gastric Adenocarcinoma: Expanding Therapy of a Recognized Target
    • Authors: JE Rogers, K Yamashita, M Sewastjanow-Silva, A Trail, RE Waters, et al.
    • Journal: Cancers
    • Year: 2023
    • Citations: 3